Liposome-based codelivery of celecoxib and doxorubicin hydrochloride as a synergistic dual-drug delivery system for enhancing the anticancer effect. [electronic resource]
Producer: 20210618Description: 285-296 p. digitalISSN:- 1532-2394
- Animals
- Antineoplastic Agents -- administration & dosage
- Celecoxib -- administration & dosage
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Drug Carriers -- chemistry
- Drug Delivery Systems
- Drug Liberation
- Drug Screening Assays, Antitumor
- Humans
- Liposomes
- Mice
- Particle Size
- Structure-Activity Relationship
- Surface Properties
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.